Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase Activity
Top Cited Papers
- 23 June 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 88 (12) , 1291-1298
- https://doi.org/10.1161/hh1201.092042
Abstract
—Diabetes mellitus (DM) is a primary risk factor for cardiovascular disease. Although recent studies have demonstrated an important role for extracellular matrix metalloproteinases (MMPs) in atherosclerosis, little is known about the effects of hyperglycemia on MMP regulation in vascular cells. Gelatin zymography and Western blot analysis revealed that the activity and expression of 92-kDa (MMP-9) gelatinase, but not of 72 kDa (MMP-2) gelatinase, were significantly increased in vascular tissue and plasma of two distinct rodent models of DM. Bovine aortic endothelial cells (BAECs) grown in culture did not express MMP-9 constitutively; however, chronic (2-week) incubation with high glucose medium induced MMP-9 promoter activity, mRNA and protein expression, and gelatinase activity in BAECs. On the other hand, high glucose culture did not change MMP-9 activity from vascular smooth muscle cells or macrophages. Electron paramagnetic resonance studies indicate that BAECs chronically grown in high glucose conditions produce 70% more ROS than do control cells. Enhanced MMP-9 activity was significantly reduced by treatment with the antioxidants polyethylene glycol–superoxide dismutase and N-acetyl-l-cysteine but not by inhibitors of protein kinase C. In conclusion, vascular MMP-9 activity is increased in DM, in part because of enhanced elaboration from vascular endothelial cells, and oxidative stress plays an important role. This novel mechanism of redox-sensitive MMP-9 expression by hyperglycemia may provide a rationale for antioxidant therapy to modulate diabetic vascular complications.Keywords
This publication has 41 references indexed in Scilit:
- Thrombospondin-1 Modulates Angiogenesisin Vitroby Up-Regulation of Matrix Metalloproteinase-9 in Endothelial CellsExperimental Cell Research, 1997
- Activation of the Leukocyte NADPH Oxidase Subunit p47phox by Protein Kinase C. A Phosphorylation-Dependent Change in the Conformation of the C-Terminal End of p47phoxBiochemistry, 1997
- Determinants of coronary vascular disease in patients with type ii diabetes mellitus and their therapeutic implicationsClinical Cardiology, 1997
- Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.Journal of Clinical Investigation, 1996
- Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal TransductionScience, 1995
- Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.Journal of Clinical Investigation, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic LesionsaAnnals of the New York Academy of Sciences, 1994
- Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase.Journal of Clinical Investigation, 1993
- Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienolsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993